Status:
COMPLETED
Evaluation of Safety and Parameters of Application Technique
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 1
Eligibility:
All Genders
Brief Summary
This study is conducted in Europe. The aim of the study is to monitor patients changing therapy from syringe to insulin delivery system as prescribed by the treating physician in Slovakia.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diabetes mellitus (type 1 or type 2)
- Treated with insulin
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
4819 Patients enrolled
Trial Details
Trial ID
NCT01516242
Start Date
October 1 2006
End Date
December 1 2007
Last Update
November 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Bratislava, Slovakia, 811 05